Farmacosmo Balance Sheet Health
Financial Health criteria checks 3/6
Farmacosmo has a total shareholder equity of €15.4M and total debt of €6.7M, which brings its debt-to-equity ratio to 43.5%. Its total assets and total liabilities are €36.4M and €21.0M respectively.
Key information
43.5%
Debt to equity ratio
€6.69m
Debt
Interest coverage ratio | n/a |
Cash | €5.07m |
Equity | €15.37m |
Total liabilities | €21.03m |
Total assets | €36.40m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: COSMO's short term assets (€20.1M) exceed its short term liabilities (€18.4M).
Long Term Liabilities: COSMO's short term assets (€20.1M) exceed its long term liabilities (€2.6M).
Debt to Equity History and Analysis
Debt Level: COSMO's net debt to equity ratio (10.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if COSMO's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COSMO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if COSMO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.